Shenzhen Kangtai Biological Products Co., Ltd.
Pharmaceutical industry · Shenzhen, Guangdong
About Shenzhen Kangtai Biological Products Co., Ltd.
Shenzhen Kangtai Biological Products Co., Ltd., known as BioKangtai, is a Chinese biopharmaceutical company founded in 1992 and headquartered in Shenzhen, Guangdong Province. Listed on Shenzhen's ChiNext market (300601), it researches, develops, manufactures and sells vaccines and other biological products for human use.
Its launched catalogue includes the hepatitis B vaccine, the Haemophilus influenzae type b conjugate vaccine, the combined DTaP/Hib vaccine, the 13-valent pneumococcal conjugate vaccine (launched in 2021), the 23-valent pneumococcal polysaccharide vaccine (2019), the Sabin-strain inactivated poliomyelitis vaccine and the varicella vaccine. The company highlights proprietary technologies in multivalent and genetic-engineering vaccines.
According to its official English website, its international business development covers six regions and more than 20 countries. Headquarters are at the Kangtai Group Building, No. 222 Kefa Road, Nanshan District, with the phone number and email published on the site itself, making direct verification easy for distributors and partners.
Its launched catalogue includes the hepatitis B vaccine, the Haemophilus influenzae type b conjugate vaccine, the combined DTaP/Hib vaccine, the 13-valent pneumococcal conjugate vaccine (launched in 2021), the 23-valent pneumococcal polysaccharide vaccine (2019), the Sabin-strain inactivated poliomyelitis vaccine and the varicella vaccine. The company highlights proprietary technologies in multivalent and genetic-engineering vaccines.
According to its official English website, its international business development covers six regions and more than 20 countries. Headquarters are at the Kangtai Group Building, No. 222 Kefa Road, Nanshan District, with the phone number and email published on the site itself, making direct verification easy for distributors and partners.